Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

8.00p
   
  • Change Today:
      0.15p
  • 52 Week High: 40.00
  • 52 Week Low: 7.02
  • Currency: UK Pounds
  • Shares Issued: 303.83m
  • Volume: 79,343
  • Market Cap: £24.31m
  • RiskGrade: 479
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
95.68% above the market average95.68% above the market average95.68% above the market average95.68% above the market average95.68% above the market average
80.65% above the sector average80.65% above the sector average80.65% above the sector average80.65% above the sector average80.65% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
14.58% below the market average14.58% below the market average14.58% below the market average14.58% below the market average14.58% below the market average
68% below the sector average68% below the sector average68% below the sector average68% below the sector average68% below the sector average
Price Book Ratio
53.54% below the market average53.54% below the market average53.54% below the market average53.54% below the market average53.54% below the market average
2.56% below the sector average2.56% below the sector average2.56% below the sector average2.56% below the sector average2.56% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
89.19% below the market average89.19% below the market average89.19% below the market average89.19% below the market average89.19% below the market average
73.91% below the sector average73.91% below the sector average73.91% below the sector average73.91% below the sector average73.91% below the sector average
Price Chg 3m
82.33% below the market average82.33% below the market average82.33% below the market average82.33% below the market average82.33% below the market average
65.22% below the sector average65.22% below the sector average65.22% below the sector average65.22% below the sector average65.22% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
61.12% below the market average61.12% below the market average61.12% below the market average61.12% below the market average61.12% below the market average
47.62% below the sector average47.62% below the sector average47.62% below the sector average47.62% below the sector average47.62% below the sector average
Momentum 20
50.22% below the market average50.22% below the market average50.22% below the market average50.22% below the market average50.22% below the market average
28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
0.67% above the market average0.67% above the market average0.67% above the market average0.67% above the market average0.67% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
18.42% below the market average18.42% below the market average18.42% below the market average18.42% below the market average18.42% below the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
35.74% below the market average35.74% below the market average35.74% below the market average35.74% below the market average35.74% below the market average
6.25% above the sector average6.25% above the sector average6.25% above the sector average6.25% above the sector average6.25% above the sector average
Operating Profit Loss
6.27% below the market average6.27% below the market average6.27% below the market average6.27% below the market average6.27% below the market average
56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
32.19% below the market average32.19% below the market average32.19% below the market average32.19% below the market average32.19% below the market average
2.33% above the sector average2.33% above the sector average2.33% above the sector average2.33% above the sector average2.33% above the sector average
Cash
5.91% below the market average5.91% below the market average5.91% below the market average5.91% below the market average5.91% below the market average
15.56% above the sector average15.56% above the sector average15.56% above the sector average15.56% above the sector average15.56% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
25.12% below the market average25.12% below the market average25.12% below the market average25.12% below the market average25.12% below the market average
63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average
Buys 1y
23.30% above the market average23.30% above the market average23.30% above the market average23.30% above the market average23.30% above the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
64.55% above the market average64.55% above the market average64.55% above the market average64.55% above the market average64.55% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 8.00p
Change Today 0.15p
% Change 1.91 %
52 Week High 40.00
52 Week Low 7.02
Volume 79,343
Shares Issued 303.83m
Market Cap £24.31m
Beta 0.01
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.34% below the market average30.34% below the market average30.34% below the market average30.34% below the market average30.34% below the market average
47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average
Price Trend
96.69% below the market average96.69% below the market average96.69% below the market average96.69% below the market average96.69% below the market average
95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average
Income Not Available
Growth
24.00% above the market average24.00% above the market average24.00% above the market average24.00% above the market average24.00% above the market average
31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 07-Jul-2025

Time Volume / Share Price
09:00 258 @ 7.67p
08:48 40,000 @ 8.00p
08:48 37,813 @ 7.90p
08:00 1,250 @ 8.00p
08:00 22 @ 7.02p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page